Shared pathogenicity features and sequences between EBV, SARS-coV-2, and HLA class I molecule-binding motifs with a potential role in autoimmunity
Y Adiguzel, N Mahroum, S Muller, M Blank… - Clinical Reviews in …, 2023 - Springer
Epstein-Barr virus (EBV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) are extraordinary in their ability to activate autoimmunity as well as to induce diverse …
2) are extraordinary in their ability to activate autoimmunity as well as to induce diverse …
[HTML][HTML] Editorial for “Post COVID-19 Syndrome in Patients with Asymptomatic/Mild Form”
A Dotan, Y Shoenfeld - Pathogens, 2023 - mdpi.com
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first reported in
December 2019, has infected numerous subjects worldwide. SARS-CoV-2 is the virus that …
December 2019, has infected numerous subjects worldwide. SARS-CoV-2 is the virus that …
Рroblems of diagnostics of dysfunctions of the olfactory analyzer of laboratory animals on the basis of behavioral and electrophysiological methods of research
AV Gorskaya, DS Vasilev - Sensornye sistemy, 2024 - journals.rcsi.science
Olfactory impairment (decreased acuity, impaired adequate identification of odorants)
reduces the quality of life of patients and can be a symptom of a wide range of pathologies of …
reduces the quality of life of patients and can be a symptom of a wide range of pathologies of …